TOLLIP and MUC5B Genetic Variants Influence the Circulating KL6, SPD, and HE4 Levels in Interstitial Lung Abnormalities

Background: Interstitial lung abnormalities (ILAs) are alterations of lung parenchyma found in approximately 5% of individuals older than 60 years. There is growing interest in identifying early biomarkers that may facilitate diagnosis and predict disease progression. Given ILA’s biological complexity, a multidimensional approach integrating genetic susceptibility and immune dysregulation is warranted. Methods: We studied 87 ILA subjects and 74 subjects without changes on high-resolution computed tomography and without respiratory symptoms. We also classified ILA subjects by progression status during 5 years of follow-up: 20 progressed, and 67 did not. This study evaluated demographic characteristics, circulating soluble proteins (KL6, SPD, and HE4), T cell polarization (Th1/Th2 balance), and selected gene polymorphisms (TERT, MUC5B, FAM13A, TOLLIP, and DSP). Results: Patients with ILA were predominantly male and showed significant abnormalities in pulmonary function tests; they had higher circulating SP-D levels (78 ± 44 versus 43 ± 31 ng/mL, p < 0.0001). Genetic variants significantly influence circulating levels; the median KL6 levels were higher in patients and controls carrying the TOLLIP rs5743890 TT genotype (0.27 ng/mL [0.01–0.71 ng/mL]) than in those with the TC genotype (0.01 ng/mL [0.00–0.19 ng/mL]). The SPD levels according to the MUC5B rs35705950 genotypes were lower in controls and patients carrying the common genotype GG (48.66 ng/mL [27.49–80.40 ng/mL] and 56.91 ng/mL [32.23–90.22 ng/mL]) than subjects with GT + TT genotypes (83.09 ng/mL [56.52–139.72 ng/mL], and 93.70 ng/mL [57.77–154.38 ng/mL]) and HE4 levels were different when the patients and controls carrying the MUC5B rs35705950 GG (2.43 pmol/mL [1.56–3.22 pmol/mL], and 2.43 pmol/mL [1.65–3.29 pmol/mL]) were compared to those with the GT genotype (1.56 pmol/mL [1.21–1.97 pmol/mL], and 1.48 pmol/mL [1.08–2.09 pmol/mL]). No difference emerged when we divided ILAs by progression. The Th1/Th2 ratio does not differ between ILAs and controls, even after polyclonal stimulation. Conclusions: Our findings provide relevant insight into the relationship between genetic background and circulating levels.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2026-10-27
DOI
https://doi.org/10.3390/diagnostics16213526
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TOLLIP and MUC5B Genetic Variants Influence the Circulating KL6, SPD, and HE4 Levels in Interstitial Lung Abnormalities

Lucero A. Ramón‐Luing, Ramcés Falfán‐Valencia, Gloría Pérez-Rubio, Ranferi Ocaña‐Guzmán et al.
4 links
Diagnostics
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

TOLLIP and MUC5B Genetic Variants Influence the Circulating KL6, SPD, and HE4 Levels in Interstitial Lung Abnormalities

Lucero A. Ramón‐Luing, Ramcés Falfán‐Valencia, Gloría Pérez-Rubio, Ranferi Ocaña‐Guzmán, Iliana Herrera, Leslie Chávez‐Galán, Ingrid Fricke-Galindo, Ivette Buendía-Roldán
article en

Abstract

Background: Interstitial lung abnormalities (ILAs) are alterations of lung parenchyma found in approximately 5% of individuals older than 60 years. There is growing interest in identifying early biomarkers that may facilitate diagnosis and predict disease progression. Given ILA’s biological complexity, a multidimensional approach integrating genetic susceptibility and immune dysregulation is warranted. Methods: We studied 87 ILA subjects and 74 subjects without changes on high-resolution computed tomography and without respiratory symptoms. We also classified ILA subjects by progression status during 5 years of follow-up: 20 progressed, and 67 did not. This study evaluated demographic characteristics, circulating soluble proteins (KL6, SPD, and HE4), T cell polarization (Th1/Th2 balance), and selected gene polymorphisms (TERT, MUC5B, FAM13A, TOLLIP, and DSP). Results: Patients with ILA were predominantly male and showed significant abnormalities in pulmonary function tests; they had higher circulating SP-D levels (78 ± 44 versus 43 ± 31 ng/mL, p < 0.0001). Genetic variants significantly influence circulating levels; the median KL6 levels were higher in patients and controls carrying the TOLLIP rs5743890 TT genotype (0.27 ng/mL [0.01–0.71 ng/mL]) than in those with the TC genotype (0.01 ng/mL [0.00–0.19 ng/mL]). The SPD levels according to the MUC5B rs35705950 genotypes were lower in controls and patients carrying the common genotype GG (48.66 ng/mL [27.49–80.40 ng/mL] and 56.91 ng/mL [32.23–90.22 ng/mL]) than subjects with GT + TT genotypes (83.09 ng/mL [56.52–139.72 ng/mL], and 93.70 ng/mL [57.77–154.38 ng/mL]) and HE4 levels were different when the patients and controls carrying the MUC5B rs35705950 GG (2.43 pmol/mL [1.56–3.22 pmol/mL], and 2.43 pmol/mL [1.65–3.29 pmol/mL]) were compared to those with the GT genotype (1.56 pmol/mL [1.21–1.97 pmol/mL], and 1.48 pmol/mL [1.08–2.09 pmol/mL]). No difference emerged when we divided ILAs by progression. The Th1/Th2 ratio does not differ between ILAs and controls, even after polyclonal stimulation. Conclusions: Our findings provide relevant insight into the relationship between genetic background and circulating levels.

DiagnosticsVol. 16(21)
Instituto Nacional de Enfermedades Respiratorias (MX)
Good health and well-being
Openalex Percentile: Top 12%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon